High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

British Journal of Cancer

Volumn 90, Issue 8, 2004, Pages 1521-1525

  Cascinu, S ^a   Scartozzi, M ^a   Labianca, R ^b   Catalano, V ^c   Silva, R R ^d   Barni, S ^e   Zaniboni, A ^f   D'Angelo, A ^g   Salvagni, S ^g   Martignoni, G ^h   Beretta, G D ^b   Graziano, F ⁱ   Berardi, R ^a   Franciosi, V ^g  

^a Azienda Ospedaliera Umberto I   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

^d Ospedale di Fabriano   (Italy)

^e Azienda Ospedaliera di Treviglio   (Italy)

^f Medical Oncology   (Italy)

^g Azienda Ospedaliera Universitaria   (Italy)

^h SAN CARLO BORROMEO HOSPITAL   (Italy)

ⁱ Ospedale di Urbino   (Italy)

Author keywords

Curative resection; Gastric cancer; Neoadjuvant; Preoperative chemotherapy

Indexed keywords

CISPLATIN; DEXAMETHASONE; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GLUTATHIONE; ONDANSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT; PELF PROTOCOL 2;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG RESPONSE; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HEART FUNCTION; HUMAN; LAPAROTOMY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; ADJUVANT THERAPY; CHEMICALLY INDUCED DISORDER; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; STOMACH TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FILGRASTIM; FLUOROURACIL; GLUTATHIONE; HUMANS; LEUCOVORIN; LEUKOPENIA; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; STOMACH NEOPLASMS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 2442494952     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601752     Document Type: Article

References (21)

1. Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM (1999) Enhanced staging and ALL chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol 17: 2403-2411
2. Ajani JA, VanCutsem E, Moiseyenko V, Tjulandin S, Fodor M, Majlis A, Boni C, Zuber E, Blattmann A (2003) Docetaxel (D), cisplatin, 5-fluorouracil compare to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naïve patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325). Proc Am Soc Clin Oncol 22: 249 (abstr 999)
3. Botet JF, Lightdale CJ, Zauber AG, Gerdes H, Winawer SJ, Urmacher C, Brennan MF (1991) Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology 181: 426-432
4. Cascinu S, Labianca R, Alessandroni P, Marcellini M, Silva RR, Pancera G, Testa E, Martignoni G, Barni S, Frontini L, Zaniboni A, Luporini G, Cellerino R, Catalano G (1997) Intensive weekly chemotherapy for advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgastrim. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). J Clin Oncol 5: 3313-3319
5. Cascinu S, Labianca R, Graziano F, Pancera G, Barni S, Frontini L, Luporini G, Cellerino R, Catalano G (1998) Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgastrim: a report from the Italian Group for the Study of Digestive Tract cancer (GISCAD). Br J Cancer 78: 390-393
6. Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H (1994) A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 5: 609-616
7. Geh JI, Glynne-Jones R, Kwok QS, Banerji U, Livingstone JI, Townsend ER, Harrison RA, Mitchell IC (2000) Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma. Clin Oncol (R Coll Radiol) 12: 182-187
8. Karpeh MS, Kelsen DP, Tepper JE (2001) Cancer of the stomach. In: Cancer Principles and Practice of Oncology, De Vita VT, Helman S, Rosemberg SA (eds) pp 1092-1126. Philadelphia: Lippincott Williams and Wilkins
9. Kelsen DP (1996) Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol 23: 379-389
10. Kelsen D, Karpeh M, Schwartz G, Gerdes H, Lightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M (1996) Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14: 1818-1828
11. Lightdale C, Botet J, Brennan M (1989) Endoscopic ultrasonography compared to computerized tomography for preoperative staging of gastric cancer. Gastrointest Endosc 35: 154-159
12. Louvet C, Andre T, Tigaud JM, Gamelin E, Douillard JY, Brunet R, Francois E, Jacob JH, Levoir D, Taamma A, Rougier P, Cvitkovic E, de Gramont A (2002) Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 20: 4543-4548
13. Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA (1999) Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 229: 303-308
14. Melcher AA, Mort D, Maughan TS (1996) Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer. Br J Cancer 74: 1651-1654
15. Plukker JT, Mulder NH, Sleijfer DT, Grond J, Verschueren RC (1991) Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78: 955-958
16. Rougier P, Lasser P, Ducreux M, Mahjoubi M, Bognel C, Elias D (1994) Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 5: 59-68
17. Schuhmacher CP, Fink U, Becker C, Busch R, Dittler HJ, Mueller J, Siewert JR (2001) Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Cancer 91: 918-927
18. Songun I, Keizer HJ, Hermans J, Klementschitsch P, de Vries JE, Wils JA, van der Bijl J, van Krieken JH, van de Velde CJ (1999) Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial. Eur J Cancer 35: 558-562
19. Sussman H, Halvorsen RA, Illescas FF, Cohan RH, Saeed M, Silverman PM, Thompson WM, Meyers WC (1988) Gastric adenocarcinoma: CT versus surgical staging. Radiology 167: 335-340
20. Wilke H, Preusser P, Fink U, Achterrath W, Meyer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR, Geerlings H (1990) New developments in the treatment of gastric carcinoma. Semin Oncol 17: S61-S70
21. Yano M, Shiozaki H, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Tsujinaka T, Monden M (2002) Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer. World J Surg 26: 1155-1159